Belpointe Asset Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-1,730
| Closed | -$94.8K | – | 3725 |
|
2022
Q4 | $94.8K | Buy |
+1,730
| New | +$94.8K | 0.01% | 1269 |
|
2021
Q4 | – | Sell |
-21,890
| Closed | -$489K | – | 1198 |
|
2021
Q3 | $489K | Sell |
21,890
-190
| -0.9% | -$4.24K | 0.03% | 513 |
|
2021
Q2 | $548K | Hold |
22,080
| – | – | 0.04% | 469 |
|
2021
Q1 | $641K | Buy |
+22,080
| New | +$641K | 0.05% | 344 |
|